-
Mashup Score: 8
Featuring perspectives from Dr Bita Fakhri, including the following topics: Overview of select presentations from ASH 2023; recent FDA approval of lisocabtagene maraleucel (0:00) 6-year follow-up from the Phase III CLL14 trial of first-line venetoclax/obinutuzumab versus chlorambucil/obinutuzumab for chronic lymphocytic leukemia (CLL) (7:36) Updates from ASH 2023 from the Phase III FLAIR study of minimal residual disease (MRD)-guided ibrutinib in combination with venetoclax for previously untreated CLL (13:28) 57-month follow-up from the Phase III GLOW trial of fixed-duration ibrutinib/venetoclax for previously untreated CLL (22:28) Current clinical role of MRD testing for CLL (28:11) Key findings from 5-year follow-up of the Phase II CAPTIVATE study for patents with CLL/small lymphocytic leukemia (SLL) with relapse after first-line fixed-duration ibrutinib/venetoclax (36:43) 6-year update from the Phase III ELEVATE-TN trial of acalabrutinib with or without obinutuzumab for treatment-n
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Featuring an interview with Prof Naveen Pemmaraju, including the following topics: Case: A woman in her mid 20s with classic blastic plasmacytoid dendritic cell neoplasm (BPDCN) who responded to combination hyper-CVAD/venetoclax (0:00) Defining and diagnosing BPDCN (5:17) Presentation, prevention and management of capillary leak syndrome (7:56) Targeting CD123 in BPDCN (12:53) Case: A man in his early 70s with TET-mutated BPDCN who had a complete response to tagraxofusp (14:21) Selection of CD123-targeted therapy for patients with BPDCN (20:05) Case: A man in his mid 60s who had a complete response to pivekimab sunirine (27:04) Future directions in the treatment of BPDCN (28:55)
Categories: General Medicine News, Hem/OncsTweet-
Research To Practice | Oncology Videos: Blastic Plasmacytoid Dendritic Cell Neoplasm | Oncology Today with Dr Neil Love and Dr Naveen Pemmaraju @doctorpemm | Blastic Plasmacytoid Dendritic Cell Neoplasm #BPDCN | https://t.co/FIExpko8ZE
-
-
Mashup Score: 1
Featuring an interview with Prof Naveen Pemmaraju, including the following topics: Case: A woman in her mid 20s with classic blastic plasmacytoid dendritic cell neoplasm (BPDCN) who responded to combination hyper-CVAD/venetoclax (0:00) Defining and diagnosing BPDCN (5:17) Presentation, prevention and management of capillary leak syndrome (7:56) Targeting CD123 in BPDCN (12:53) Case: A man in his early 70s with TET-mutated BPDCN who had a complete response to tagraxofusp (14:21) Selection of CD123-targeted therapy for patients with BPDCN (20:05) Case: A man in his mid 60s who had a complete response to pivekimab sunirine (27:04) Future directions in the treatment of BPDCN (28:55)
Categories: General Medicine News, Hem/OncsTweet-
Research To Practice | Oncology Videos: Blastic Plasmacytoid Dendritic Cell Neoplasm | Oncology Today with Dr Neil Love and Dr Naveen Pemmaraju @doctorpemm | Blastic Plasmacytoid Dendritic Cell Neoplasm #BPDCN | https://t.co/FIExpko8ZE
-
-
Mashup Score: 1Research To Practice | Oncology Videos: Soft Tissue Sarcomas | Oncology Today with Dr Neil Love: Advances in Soft Tissue Sarcomas - 3 year(s) ago
Featuring an interview with Dr Mark Agulnik, including the following topics: What we need to know about sarcomas in 2022 (0:00) Currently available targeted therapies for sarcoma (7:57) Novel agents available for patients with sarcoma (17:22) Role of molecular testing in the management of sarcoma (24:36) New developments in therapy for desmoid tumors (30:21)
Categories: Hem/Oncs, Latest HeadlinesTweet-
Great talk on Soft Tissue Sarcomas in 2022; by @AgulnikMd https://t.co/GLWxXPBZuH Thanks @DrNeilLove
-
I enjoyed my time with @DrNeilLove dissecting some of the most recent updates in CLL/SLL/Richter’s transformation! https://t.co/yoiJr49sgs